| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Nonalcoholic fatty liver disease", "2": "Sphingolipid metabolism overview", "3": "Glycosaminoglycan degradation", "4": "Sphingolipid metabolism in senescence", "5": "Sphingolipid metabolism integrated pathway", "6": "Degradation pathway of sphingolipids including diseases", "7": "Sphingolipid pathway", "8": "Mitochondrial complex iv assembly", "9": "Vitamin d receptor pathway", "10": "Overlap between signal transduction pathways contributing to lmna laminopathies", "11": "Intracellular trafficking proteins involved in cmt neuropathy", "12": "Mitochondrial complex i assembly model oxphos system", "13": "Ferroptosis", "14": "Glycerophospholipid biosynthetic pathway", "15": "Cholesterol metabolism with bloch and kandutschrussell pathways", "16": "Metapathway biotransformation phase i and ii", "17": "Oxidative phosphorylation", "18": "Allograft rejection", "19": "Adipogenesis", "20": "Nuclear receptors metapathway", "21": "Alzheimers disease and mirna effects", "22": "Mecp2 and associated rett syndrome", "23": "Alzheimers disease", "24": "Ppar signaling pathway", "25": "H19 action rbe2f1 signaling and cdkbetacatenin activity"} |